Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration
Pharmaceutics · 15.02.2024 · 16 (2) · 273
DOI: 10.3390/pharmaceutics16020273 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 15.02.2024. Verfasst von Mozan Hassan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United Arab Emirates University.
Abstract (Originalsprache)
Recently, nanotechnologies have become increasingly prominent in the field of bone tissue engineering (BTE), offering substantial potential to advance the field forward. These advancements manifest in two primary ways: the localized application of nanoengineered materials to enhance bone regeneration and their use as nanovehicles for delivering bioactive compounds. Despite significant progress in the development of bone substitutes over the past few decades, it is worth noting that the quest to identify the optimal biomaterial for bone regeneration remains a subject of intense debate. Ever since its initial discovery, poly(lactic-co-glycolic acid) (PLGA) has found widespread use in BTE due to its favorable biocompatibility and customizable biodegradability. This review provides an overview of contemporary advancements in the development of bone regeneration materials using PLGA polymers. The review covers some of the properties of PLGA, with a special focus on modifications of these properties towards bone regeneration. Furthermore, we delve into the techniques for synthesizing PLGA nanoparticles (NPs), the diverse forms in which these NPs can be fabricated, and the bioactive molecules that exhibit therapeutic potential for promoting bone regeneration. Additionally, we addressed some of the current concerns regarding the safety of PLGA NPs and PLGA-based products available on the market. Finally, we briefly discussed some of the current challenges and proposed some strategies to functionally enhance the fabrication of PLGA NPs towards BTE. We envisage that the utilization of PLGA NP holds significant potential as a potent tool in advancing therapies for intractable bone diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomy, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 15551, United Arab Emirates.
ORCID-Profile: Mozan Hassan, Hiba Atiyah Abdelnabi, Sahar Mohsin
Förderung
- United Arab Emirates University
Zitieren
APA
Hassan, M., Abdelnabi, H. A., & Mohsin, S. (2024). Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration. Pharmaceutics, 16(2), 273. https://doi.org/10.3390/pharmaceutics16020273
Vancouver
Hassan M, Abdelnabi HA, Mohsin S. Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration. Pharmaceutics. 2024;16(2):273. doi:10.3390/pharmaceutics16020273
BibTeX
@article{Hassan2024,
author = {Hassan, Mozan and Abdelnabi, Hiba Atiyah and Mohsin, Sahar},
title = {Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {2},
pages = {273},
doi = {10.3390/pharmaceutics16020273}
}
EUVIMED